Return to homepagePandemic Pact

AFRACOV2 Serological study of SARS-CoV-2 in blood donors in sub-Saharan Africa: evaluation of viral spread through the Transfusion Research Group in Francophone Africa.

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    ANR

  • Principal Investigator

    Pierre Cappy

  • Research Location

    Burkina Faso, Cameroon
    …

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The AFRACOV2 project proposes to evaluate the spread of SARS-CoV-2 in sub-Saharan Africa by a seroprevalence study among blood donors from six countries of the Transfusion Research Group of Francophone Africa (Burkina-Faso, Cameroon, Madagascar , Mali, Niger and Central African Republic). On each sample, the total anti-SARS-CoV-2 antibodies will be looked for by an ELISA test. The serological data will be adjusted in relation to the demographic data and compared to the pre-pandemic and pandemic contexts.